Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2004 Nov 27;329(7477):1248-9.
doi: 10.1136/bmj.329.7477.1248.

Angiotensin receptor blockers and myocardial infarction

Subodh Verma, Marty Strauss
Editorial

Angiotensin receptor blockers and myocardial infarction

Subodh Verma et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment in

References

    1. Is GSK guilty of fraud? Lancet 2004;363: 1919. - PubMed
    1. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. VALUE Trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363: 2022-31. - PubMed
    1. Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J. Heart outcomes prevention evaluation (HOPE) study. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet 2001;358: 2130-1. - PubMed
    1. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet 2003;362: 772-6. - PubMed
    1. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 2003;362: 777-81. - PubMed

Publication types

MeSH terms